Invesco
SBIO.L
IE00BQ70R696
Invesco NASDAQ Biotech UCITS ETF Acc
Loading chart...

Analytics & Allocation

Detailed breakdown by growth drivers, valuation & quality, and asset allocation

Synthetic Replication Note (Swap ETF)

Synthetic (Swap)

The reported holdings, valuation ratios (P/E, etc.), and analyst estimates reflect the fund's underlying collateral/substitute basket, not the actual composition of the tracked index.

Growth Drivers (Estimates)

Largest contributors to earnings and revenue growth

Balance Sheet & Financial Health

Aggregated leverage and valuation structure

Weighted P/E
18.06
Weighted Fwd P/E
59.17
Avg P/FCF
29.01
Avg FCF Yield
0.82%
Avg EV / EBITDA
48.43
Avg EV / Revenue
104.3
Avg Price-to-Book (P/B)
17.36
Avg Price-to-Sales (P/S)
122.78
Avg Dividend Yield
0.00%
P/E Compression (Trailing vs Fwd)
+227.66%
Avg Debt-to-Equity (D/E)
147.64%
<50% (53.71%) 50-150% (13.97%) >150% (23.81%) Unreported (8.51%)

Profitability Analysis

246 Holdings Count
Profitable 66.18%
Profitable 66.18%
85 Holdings Count (34.55%)
Unprofitable 33.82%
161 Holdings Count (65.45%)

ETF Concentration (Cumulative Weight)

Cumulative weight of positions (Lorenz curve)

Moderate Concentration
Top 5
33.0%
Top 10
44.4%
Top 25
63.7%
50% Threshold
Top 14
The top 10 positions account for 44.4% of the portfolio. A healthy balance between a strong core and diversification. The steeper the curve initially rises, the more the largest positions dominate the fund volume.

Geographic Distribution

16 Countries
Loading TopoJSON Map...
0% (No exposure)
Tiers:
Low (0.1%+)
Med (22.0%+)
High (57.1%+)
Top (79.1%+)

Country Breakdown

Max: 87.91%
US US US
87.91%
GB GB GB
2.50%
NL NL NL
2.20%
IE IE IE
1.70%
CH CH CH
1.42%
DK DK DK
1.25%
FR FR FR
1.13%
DE DE DE
0.76%
CA CA CA
0.74%
LU LU LU
0.11%
ES ES ES
0.06%
AU AU AU
0.05%
CN CN CN
0.05%
IL IL IL
0.03%
BE BE BE
0.03%
TW TW TW
0.01%

Sector Distribution

2 Sector
Healthcare
99.96%
Unknown
0.04%

Industry Distribution

8 Industries
Biotechnology
67.63%
Drug Manufacturers - General
18.58%
Drug Manufacturers - Specialty & Generic
6.74%
Diagnostics & Research
5.51%
Health Information Services
0.69%
Medical Devices
0.68%
Medical Care Facilities
0.13%
Unknown
0.04%

Market Cap Distribution

246 Holdings Count
Mega Cap (> 200B)
(1) 8.06%
Large Cap (10B - 200B)
(29) 58.69%
Mid Cap (2B - 10B)
(66) 23.71%
Small / Micro Cap (< 2B)
(150) 9.54%
ende